Evidence map›Paper›PMID 33997460›Full record

ArticleContemporary clinical trials communications2021

SWOG S1820: Altering Intake, Managing Symptoms for bowel dysfunction in survivors of Rectal Cancer (The AIMS-RC intervention trial).

Virginia Sun, Tracy E Crane, Kathryn B Arnold, Katherine Guthrie, Sarah Freylersythe, Christa Braun-Inglis, Lee Jones, Stacey A Cohen, Mazin Al-Kasspooles, Robert S Krouse and 1 more

Open access · goldAbstract read
In one paragraph

Article in Contemporary clinical trials communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Baseline characteristics and recruitment for SWOG S1820: altering intake, managing bowel symptoms in survivors of rectal cancer (AIMS-RC).Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 1 country.

Virginia SunDepartment of Population Sciences, City of Hope, Duarte, CA, USA.
Tracy E CraneCollege of Nursing, University of Arizona, Tucson, AZ, USA.
Kathryn B ArnoldSWOG Statistics and Data Management Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Katherine GuthrieSWOG Statistics and Data Management Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Sarah FreylersytheUniversity of Arizona Cancer Center, Tucson, AZ, USA.
Christa Braun-InglisUniversity of Hawaii Cancer Center, Honolulu, HI, USA.
Lee JonesResearch Advocate, SWOG Cancer Research Network, San Antonio, TX, USA.
Stacey A CohenUniversity of Washington, Seattle, WA, USA.
Mazin Al-KasspoolesUniversity of Kansas, Kansas City, KS, USA.
Robert S KrousePerelman School of Medicine, University of Pennsylvania and the Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, PA, USA.
Cynthia A ThomsonUniversity of Arizona Cancer Center, Tucson, AZ, USA.
University of Arizona · USFred Hutch Cancer Center · USCity of Hope · USPhiladelphia VA Medical Center · USSWOG Cancer Research Network · USUniversity of Hawaiʻi at Mānoa · USUniversity of Kansas · USUniversity of Washington · US

Funding

SWOG NCORP Research BaseUG1CA189974 · NCI · THE HOPE FOUNDATION · PI CHARLES D. BLANKE, DAWN HERSHMAN · 2014 to 2026
$80.6M
Altering Intake and Managing Symptoms in Rectal Cancer Survivors: A Multimodal Diet Modification Intervention for Bowel DysfunctionR21CA236057 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI SUN, VIRGINIA CHIH-YI, THOMSON, CYNTHIA A. · 2019 to 2020
$427k
NCI NIH HHS R21 CA236057NCI NIH HHS UG1 CA189974
6 · The paper itself

Abstract

objectiveTo describe the study protocol of SWOG S1820, a trial of the Altering Intake, Managing Symptoms intervention for bowel dysfunction in survivors of Rectal Cancer (AIMS-RC).

designSWOG S1820 is a multi-site, randomized trial of 94 post-treatment survivors of rectal cancer, comparing the intervention and attention control arms.

settingAffiliated institutions of the National Cancer Institute (NCI)-supported National Community Oncology Research Program (NCORP) and the National Clinical Trial Network (NCTN).

participantsSurvivors of rectal cancer who are between 6 and 24 months after treatment completion.

interventionAIMS-RC is a 17-week, 10 session telephone coaching program to help survivors of rectal cancer track their symptoms and improve their diets for better health and bowel function. It includes telephone-based coaching, resource manual, and personalized text/email messaging for motivation in between the telephone sessions.

main outcome measuresBowel function, low anterior resection syndrome score, quality of life (QOL), dietary quality, motivation, self-efficacy, positive/negative affect, feasibility, adherence, retention, acceptability. ANALYSIS: Thirty-seven participants per arm (74 total) provide 80% power to detect this 0.5 standard deviation effect size, based on a two-sample

Indexed as

Bowel dysfunctionDietQOLRectal cancerSurvivorship

Identifiers

PMID33997460
PMCPMC8105629
OpenAlexW3155849966

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.